Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.83 USD
+0.02 (2.16%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $0.82 -0.01 (-1.49%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Karyopharm Therapeutics (KPTI) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.29 per share. This reflects a positive earnings surprise of 31.03%. Look out for KPTI's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 13.33%.
Earnings History
Price & Consensus
Zacks News for KPTI
Earnings Preview: Assertio (ASRT) Q2 Earnings Expected to Decline
KPTI: What are Zacks experts saying now?
Zacks Private Portfolio Services